The four KDM3B pathogenic mutations reported to date have been associated with four different cancers: Wilms tumour and hepatoblastoma in our study, and acute myeloid leukaemia and Hodgkin lymphoma in the study by Diets and colleagues.20 Here, KDM3B is linked to Hodgkins lymphoma.